Taxus Cardium Pharmaceuticals Group Inc (CRXM)

[stocktrademan]

$CRXM recent news/filings

bullish
high green cmf indicator values

## source: finance.yahoo.com

Fri, 15 May 2015 13:30:19 GMT ~ Angionetics Presents at the 2015 American Society of Gene & Cell Therapy Conference On Generx® Angiogenic Phase 3 Gene Therapy Program

[at noodls] - SAN DIEGO, May 15, 2015 /PRNewswire/ -- Angionetics Inc., a majority-owned operating unit of Taxus Cardium Pharmaceuticals Group (Symbol: CRXM), today announced a presentation at the 18th Annual American ...

read full: http://www.noodls.com/view/664F459719298F06A6C22DB93ACEEAE74A176EC9
*********************************************************

Fri, 15 May 2015 13:00:00 GMT ~ Angionetics Presents at the 2015 American Society of Gene & Cell Therapy Conference On Generx® Angiogenic Phase 3 Gene Therapy Program

[PR Newswire] - SAN DIEGO, May 15, 2015 /PRNewswire/ -- Angionetics Inc., a majority-owned operating unit of Taxus Cardium Pharmaceuticals Group (CRXM), today announced a presentation at the 18th Annual American Society of Gene & Cell Therapy Conference on the Phase 3 Generx® angiogenic gene therapy program. The presentation was given at the scientific symposium entitled "Frontiers of Cardiovascular Gene and Cell Therapy" which was held in New Orleans, Louisiana. The review and clinical update, entitled "Optimization of Generx [Ad5FGF-4] Clinical Trial Design for Refractory Angina: Interim Results of the ASPIRE Phase 3 Clinical Study" was presented by the Company's Chief Scientific Officer, Gabor M. Rubanyi, M.D., Ph.D. Dr. Rubanyi outlined the current scientific knowledge about the mechanistic basis of adaptive coronary collateral growth, the biological processes that are targeted by therapeutic angiogenesis, recent discoveries based on Company-sponsored pre-clinical and clinical research, and provided an update on the Generx angiogenic gene therapy Phase 3 international clinical study.

read full: http://finance.yahoo.com/news/angionetics-presents-2015-american-society-130000346.html
*********************************************************

Mon, 11 May 2015 13:00:00 GMT ~ Angionetics Presents At 2015 Annual Marcum MicroCap Conference On Business And Generx® Clinical Development Activities

[PR Newswire] - SAN DIEGO, May 11, 2015 /PRNewswire/ -- Angionetics Inc., a majority-owned subsidiary of Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM), announced today that it will be a featured presenter at the 4th Annual 2015 Marcum MicroCap Conference on Wednesday, May 27, 2015 in New York City at the Grand Hyatt Hotel. The Company's presentation, which will be made by the CEO of Angionetics, Chris Reinhard, will cover recent business and Generx® clinical development activities. A copy of the presentation is now available on the Angionetics website (www.angionetics.com).

read full: http://finance.yahoo.com/news/angionetics-presents-2015-annual-marcum-130000933.html
*********************************************************

Mon, 13 Apr 2015 21:29:07 GMT ~ TAXUS CARDIUM PHARMACEUTICALS GROUP INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial St


read full: http://biz.yahoo.com/e/150413/crxm8-k.html
*********************************************************

Mon, 13 Apr 2015 13:00:00 GMT ~ Angionetics Initial Equity Funding to Advance as Independent Company to Develop and Commercialize Phase 3 Generx® Gene Therapy Product Candidate

[PR Newswire] - SAN DIEGO, April 13, 2015 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (trading symbol: CRXM) today announced that it has entered into a binding term sheet with Shenzhen Qianhai Taxus Industry ...

read full: http://finance.yahoo.com/news/angionetics-initial-equity-funding-advance-130000966.html
*********************************************************

$CRXM charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$CRXM company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/CRXM/company-info
Ticker: $CRXM
OTC Market Place: OTC Pink Limited
CIK code: 0000772320
Company name: Taxus Cardium Pharmaceuticals Group, Inc.
Company website: http://www.cardiumthx.com
Incorporated In: DE, USA

Business Description: Cardium Therapeutics is a health sciences and regenerative medicine company focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs that have definable pathways to commercialization, partnering and other economic monetizations. Cardium's current medical opportunities portfolio, which is focused on health sciences and regenerative medicine, includes the Tissue Repair Company, Cardium Biologics, and the Company's in-house MedPodium Health Sciences healthy lifestyle product platform. The Company's lead commercial product Excellagen(R) topical gel for wound care management, has recently received FDA clearance for marketing and sale in the United States. Cardium's lead clinical development product candidate Generx(R) is a DNA-based angiogenic biologic intended for the treatment of patients with myocardial ischemia due to coronary artery disease. In addition, consistent with its capital-efficient business model, Cardium continues to actively evaluate new technologies and business opportunities. In July 2009, Cardium completed the sale of its InnerCool Therapies medical device business to Royal Philips Electronics, the first asset monetization from the Company's biomedical investment portfolio.Less >>

$CRXM share structure

## source: otcmarkets.com

Market Value: $5,539,045 a/o May 15, 2015
Shares Outstanding: 12,308,988 a/o Aug 05, 2014
Float: Not Available
Authorized Shares: 200,000,000 a/o Sep 30, 2013
Par Value: 0.0001

$CRXM extra dd links

Company name: Taxus Cardium Pharmaceuticals Group, Inc.
Company website: http://www.cardiumthx.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CRXM+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CRXM+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CRXM+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CRXM/news - http://finance.yahoo.com/q/h?s=CRXM+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CRXM/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CRXM/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CRXM+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CRXM
DTCC (dtcc.com): http://search2.dtcc.com/?q=Taxus+Cardium+Pharmaceuticals+Group%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Taxus+Cardium+Pharmaceuticals+Group%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Taxus+Cardium+Pharmaceuticals+Group%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.cardiumthx.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.cardiumthx.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.cardiumthx.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CRXM
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000772320&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CRXM/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CRXM/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CRXM&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CRXM
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CRXM/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CRXM+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CRXM+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CRXM
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CRXM
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CRXM+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CRXM/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CRXM+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CRXM.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CRXM
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CRXM/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CRXM/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CRXM
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CRXM
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CRXM:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CRXM
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CRXM



$CRXM DD Notes ~ http://www.ddnotesmaker.com/CRXM